Angiographically assessed coronary arterial patency and reocclusion in patients with acute myocardial infarction treated with anistreplase: Results of the anistreplase reocclusion multicenter study (ARMS)
- 1 August 1991
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 68 (4) , 296-300
- https://doi.org/10.1016/0002-9149(91)90822-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Reocclusion three months after successful thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activating complexThe American Journal of Cardiology, 1990
- Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS studyThe Lancet, 1990
- Multicenter trial of intravenous Anisoylated Plasminogen Streptokinase Activator Complex (APSAC) in acute myocardial infarction: Effects on infarct size and left, ventricular functionJournal of the American College of Cardiology, 1989
- A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987
- Intravenous Anisoylated Plasminogen Streptokinase Activator Complex versus Intravenous Streptokinase in Evolving Myocardial InfarctionDrugs, 1987
- Effects of early intracoronary streptokinase on infarct size estimated from cumulative enzyme release and on enzyme release rate: A randomized trial of 533 patients with acute myocardial infarctionAmerican Heart Journal, 1986
- Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarctionJournal of the American College of Cardiology, 1986
- Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survivalJournal of the American College of Cardiology, 1986
- RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985